Fintech developer Ayondo is set to list on the Singapore Exchange at a $158m valuation, giving ProSiebenSat.1 an exit.

Six years after it spun out SAP Ventures, the enterprise software producer has formed a corporate venturing arm called SAP.IO Fund together with an incubator scheme.

The commercialisation firm has issued 7.5 million shares to raise $3.7m in fresh funds.

Johnson & Johnson and GlaxoSmithKline have contributed to a series B round for Pulmocide, a respiratory therapy spinout of Imperial College London.

Touchstone Innovations, which previously led a series A in 2013, has put $3.7m into the series B round and participated alongside several corporates such as GlaxoSmithKline.

Touchstone Innovations, which co-founded the cellular immunotherapy developer in 2007, has contributed to another funding round.

Asia Pacific Internet Group led the domestic services platform's latest round, in which it raised $10.8m, reportedly at a lower valuation than its $47m series B.